Induced pluripotent stem cell-derived cardiomyocytes-more show than substance?

Authors :: Ormrod B
Ehler E
Source :: Biophysical reviews [Biophys Rev] 2023 Jul 19; Vol. 15 (6), pp. 1941-1950. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Publication Year :: 2023
Abstract: Cardiomyocytes that are derived from human-induced pluripotent stem cells (iPSC-CM) are an exciting tool to investigate cardiomyopathy disease mechanisms at the cellular level as well as to screen for potential side effects of novel drugs. However, currently their benefit is limited due to their fairly immature differentiation status under conventional culture conditions. This review is mainly aimed at researchers outside of the iPSC-CM field and will describe potential pitfalls and which features at the level of the myofibrils would be desired to make them a more representative model system. We will also discuss different strategies that may help to achieve these.<br />Competing Interests: Conflict of interestThe authors declare no competing interests.<br /> (© The Author(s) 2023.)